Harvard Bioscience Inc. (HBIO)
0.38
-0.01 (-2.54%)
At close: Apr 25, 2025, 3:59 PM
0.40
4.68%
After-hours: Apr 25, 2025, 05:46 PM EDT
Harvard Bioscience Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Instruments, Equipment, Software, and Accessories Revenue | 20.54M | 22.76M | 26.45M | 23.5M | 27.27M | 28.49M | 27.16M | 25.7M | 27.77M | 27.54M | 31.81M | 28.48M | 27.99M | 25.83M |
| Instruments, Equipment, Software, and Accessories Revenue Growth | -9.74% | -13.97% | +12.57% | -13.82% | -4.30% | +4.92% | +5.65% | -7.42% | +0.82% | -13.43% | +11.68% | +1.76% | +8.38% | n/a |
| Service, Maintenance, and Warranty Contracts Revenue | 1.43M | 1.75M | 1.7M | 1.86M | 1.49M | 1.48M | 1.27M | 1.22M | 1.44M | 1.24M | 1.24M | 1.18M | 1.21M | 1.16M |
| Service, Maintenance, and Warranty Contracts Revenue Growth | -18.60% | +3.24% | -8.86% | +24.95% | +0.61% | +16.69% | +4.35% | -15.66% | +16.37% | -0.32% | +5.60% | -2.24% | +3.70% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|
| Europe Revenue | 32.8M | 30.69M | 35.77M | 4.63M | 82K |
| Europe Revenue Growth | +6.89% | -14.20% | +673.01% | +5542.68% | n/a |
| Greater China Revenue | 18.49M | 16.39M | 8.49M | n/a | 4.74M |
| Greater China Revenue Growth | +12.78% | +93.09% | n/a | n/a | n/a |
| Rest Of The World Revenue | 12.76M | 16.34M | 49.83M | n/a | n/a |
| Rest Of The World Revenue Growth | -21.95% | -67.20% | n/a | n/a | n/a |
| United States Revenue | 48.2M | 49.91M | n/a | n/a | n/a |
| United States Revenue Growth | -3.42% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.56M | 11.08M | 11.87M | 11.51M | 11.54M | 11.53M | 12.31M | 11.81M | 12.14M | 12.57M | 13.01M | 13.46M | 11.64M | 12.13M | 11.72M | 11.15M | 9.99M | 9.95M | 12.34M | 46.02M | 11.9M | 10.58M | 11.96M | 12.55M | 10.68M | 11.57M | 11.03M | 10.36M | 9.62M | 9.39M | 10.25M | 10.26M | 9.81M | 10.32M | 11.05M | 10.3M | 10.03M | 10.05M | 10.03M |
| Selling, General, and Administrative Revenue Growth | -4.71% | -6.62% | +3.14% | -0.29% | +0.07% | -6.34% | +4.24% | -2.73% | -3.38% | -3.41% | -3.31% | +15.61% | -4.02% | +3.50% | +5.09% | +11.66% | +0.38% | -19.36% | -73.19% | +286.82% | +12.47% | -11.51% | -4.76% | +17.57% | -7.70% | +4.87% | +6.51% | +7.71% | +2.44% | -8.46% | -0.04% | +4.61% | -5.00% | -6.59% | +7.32% | +2.62% | -0.17% | +0.20% | n/a |
| Research and Development Revenue | 2.57M | 2.63M | 2.88M | 3.15M | 2.76M | 2.96M | 2.9M | 2.85M | 2.76M | 3.5M | 3.22M | 2.95M | 2.66M | 2.7M | 2.49M | 2.35M | 1.95M | 1.9M | 2.49M | 10.71M | 2.56M | 2.77M | 2.73M | 3.04M | 2.78M | 2.76M | 2.4M | 1.53M | 1.54M | 1.3M | 1.28M | 1.16M | 1.31M | 1.5M | 1.43M | 1.53M | 1.43M | 1.71M | 1.75M |
| Research and Development Revenue Growth | -2.25% | -8.98% | -8.41% | +14.13% | -6.66% | +2.07% | +1.68% | +3.11% | -20.99% | +8.60% | +9.12% | +10.94% | -1.52% | +8.60% | +5.87% | +20.52% | +2.74% | -23.82% | -76.76% | +317.90% | -7.47% | +1.32% | -10.18% | +9.41% | +0.91% | +14.82% | +57.40% | -0.78% | +18.67% | +0.86% | +11.16% | -11.69% | -12.85% | +5.40% | -6.98% | +7.43% | -16.80% | -1.95% | n/a |
| Sales and Marketing Revenue | 5.52M | 5.39M | 5.9M | 6.22M | 5.73M | 6.18M | 5.98M | 5.95M | 5.82M | 6.59M | 6.69M | 7.34M | 6.18M | 5.73M | 5.39M | 5.47M | 4.59M | 4.28M | 5.58M | 23.26M | 5.29M | 5.77M | 6.31M | 6.47M | 6.02M | 6.31M | 5.65M | 5.92M | 5.08M | 4.98M | 5.05M | 5.29M | 5.01M | 5.09M | 5.1M | 5.22M | 5.03M | 5.13M | 5.2M |
| Sales and Marketing Revenue Growth | +2.28% | -8.62% | -5.08% | +8.51% | -7.22% | +3.35% | +0.50% | +2.22% | -11.66% | -1.50% | -8.93% | +18.76% | +7.91% | +6.39% | -1.54% | +19.22% | +7.22% | -23.30% | -76.02% | +339.44% | -8.25% | -8.50% | -2.49% | +7.41% | -4.56% | +11.74% | -4.71% | +16.61% | +1.99% | -1.31% | -4.61% | +5.71% | -1.57% | -0.31% | -2.30% | +3.86% | -1.95% | -1.37% | n/a |